PATENT CLAIM ANALYSIS

Application Number: 15746208
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "258100"]

Abstract:
Provided are a novel compound or a salt thereof, and a pharmaceutical composition comprising the same, which selectively and strongly inhibit JAK3, exhibit an excellent activity for suppressing the growth of human peripheral blood monocytes and an excellent oral absorbability, and exhibits an activity of inhibiting IL-2-induced IFN-γ production in vivo. A compound represented by formula (I) [wherein X represents —CH═CH—, —NH—, a sulfur atom or an oxygen atom; and n represents an integer of 0 to 2], or a salt thereof.

Claim (Index 18):
A method for treating a disease involving JAK3, comprising administering an effective amount of the compound or salt thereof according to  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.47692
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15112070', '15752635', '15404253', '15307036', '15507409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7287647199265578
- 35 USC 102 Novelty (BERT): 0.5101754595429142
- Combined Prediction Score: 0.7069057938881934
- Mean Citation Score: 266.979346
- Max Citation Score: 285.7120700000001
- Similarity Product: 235.30748649809428

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test